We hypothesised that if APS and SLE/APS- IgG inhibited FXa on their own but were binding to different epitopes on the active site of FXa then an appreciable increase in inhibition of FXa activity would be observed with the mixed APS/SLE IgG preparations compared with individual APS or SLE samples. This evidence concerns the gene F10 and systemic lupus erythematosus.